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XIAP is a potent suppressor of apoptosis that directly
inhibits specific members of the caspase family of cysteine
proteases. Here we demonstrate a novel role for XIAP in
the control of intracellular copper levels. XIAP was found
to interact with MURR1, a factor recently implicated in
copper homeostasis. XIAP binds to MURR1 in a manner
that is distinct from that utilized by XIAP to bind caspases,
and consistent with this, MURR1 did not affect the anti-
apoptotic properties of XIAP. However, cells and tissues
derived from Xiap-deficient mice were found to contain
reduced copper levels, while suppression of MURR1 re-
sulted in increased intracellular copper in cultured cells.
Consistent with these opposing effects, XIAP was observed
to negatively regulate MURR1 protein levels by the forma-
tion of K48 polyubiquitin chains on MURR1 that promote
its degradation. These findings represent the first de-
scribed phenotypic alteration in Xiap-deficient mice and
demonstrate that XIAP can function through MURR1 to
regulate copper homeostasis.
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Introduction
The inhibitor of apoptosis (iap) genes were originally identi-
fied in baculoviruses (Crook et al, 1993), and homologs have
subsequently been identified in a wide range of genomes. The
antiapoptotic activity of IAPs was the first property of these
proteins to be noted, and this has been largely attributed to
their ability to directly inhibit members of the caspase family
(Devereaux et al, 1997). However, IAPs have been implicated
in a number of diverse cellular functions seemingly unrelated
to caspase inhibition. In particular, several IAPs are known to
participate in cell division and cytokinesis (Uren et al, 2000),
while other family members have been shown to function in
distinct signal transduction pathways (Rothe et al, 1995;
Yamaguchi et al, 1999; Birkey Reffey et al, 2001). IAPs contain
between one and three imperfect repeats of an approximately
65-residue motif termed the baculoviral IAP repeat (BIR).
Many IAPs also contain a carboxy-terminal RING finger
domain that possesses E3 ubiquitin ligase activity and has
been implicated in proteasome-mediated degradation of var-
ious protein targets (Yang et al, 2000; Li et al, 2002).
One mammalian member of this family is X-linked IAP
(XIAP), a 56-kDa protein comprised of three amino-terminal
BIR domains and a RING domain at the carboxyl terminus
(Holcik and Korneluk, 2001). XIAP has potent antiapoptotic
properties, and has been shown to directly suppress caspases
through elements within and immediately adjacent to its
second and third BIRs (Chai et al, 2001; Huang et al, 2001;
Riedl et al, 2001). The antiapoptotic activity of XIAP can itself
be suppressed by two mitochondrial proteins, Smac/DIABLO
and Omi/HtrA2 (Du et al, 2000; Verhagen et al, 2000; Hegde
et al, 2001; Martins et al, 2001; Suzuki et al, 2001a), which are
released from mitochondria into the cytoplasm during apop-
tosis. These molecules bind to the same domains in XIAP that
mediate its interactions with caspases and act as negative
regulators of the protective properties of XIAP by releasing
XIAP from caspases (Liu et al, 2000; Wu et al, 2000;
Srinivasula et al, 2001), or in the case of Omi/HtrA2, also
by promoting the proteolytic cleavage of XIAP (Srinivasula
et al, 2003; Yang et al, 2003). In addition to the involvement
of XIAP in caspase inhibition, other roles for this molecule
have been demonstrated. XIAP has been implicated in several
intracellular signaling cascades, including the c-Jun N-term-
inal kinase (JNK) pathway (Sanna et al, 1998, 2002), the
nuclear factor-kB (NF-kB) pathway (Hofer-Warbinek et al,
2000; Levkau et al, 2001), and the transforming growth
factor-b (TGF-b) pathway (Yamaguchi et al, 1999; Birkey
Reffey et al, 2001). Many of these signaling cascades are
also involved in the cellular response to stress, including
oxidative stress (Mercurio and Manning, 1999; Martindale
and Holbrook, 2002). In addition, upregulation of XIAP
expression during cellular stress has been observed, thought
to result from Cap-independent translation mediated by an
internal ribosomal entry site present in its mRNA (Holcik
et al, 1999). Therefore, besides the ability of XIAP to inhibit
apoptotic cell death, a more general role for this molecule can
be proposed as a factor that participates in the response to
cellular stress.
Copper is essential for the enzymatic activity of a number
of housekeeping genes, such as superoxide dismutase, and it
plays a role in oxidative stress damage through free radical
formation (Puig and Thiele, 2002). Important insights into the
regulation of copper homeostasis in mammalian cells were
gleaned after the isolation of copper transporters, some of
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which are responsible for human diseases (Mercer, 2001).
Recently, a novel gene, MURR1, has been implicated in the
regulation of copper homeostasis in mammals. This gene was
found by positional cloning to be responsible for an auto-
somal recessive form of copper toxicosis that affects a specific
canine strain (Bedlington terriers) (van De Sluis et al, 2002).
Dogs affected were found to harbor a mutation in this gene
that leads to an mRNA lacking exon 2 (van De Sluis et al,
2002), and MURR1 protein was undetectable in affected
animals (Klomp et al, 2003). The mechanism by which
MURR1 is involved in copper regulation remains unknown,
although the ability of this protein to interact with the copper
transporter ATP7B has been recently reported (Tao et al,
2003).
Here we describe a novel function of XIAP in the regulation
of cellular copper levels that is mediated by its ability to
function as an E3 ubiquitin ligase for MURR1. An interaction
between XIAP and MURR1 was identified and reduced copper
levels were found in liver tissue and fibroblasts derived from
Xiap-deficient mice. XIAP was observed to function as a
negative regulator of MURR1 protein levels and to direct
the ubiquitination of MURR1 by K48 polyubiquitin chains.
Taken together, these data reveal a previously unrecognized
role for XIAP in copper homeostasis.
Results
Identification of MURR1 as an XIAP-associated factor
To identify novel XIAP binding proteins, full-length XIAP was
used to screen a yeast two-hybrid library prepared from
human liver cDNA. This screen led to the identification of
MURR1 as an XIAP binding protein. Coprecipitation studies
were performed with lysates from 293 cells to determine
whether endogenous XIAP and MURR1 proteins interact in
mammalian cells. XIAP was readily detected in MURR1
immunoprecipitates (Figure 1A), but not in immunoprecipi-
tates prepared using a control serum, indicating a specific
interaction between MURR1 and XIAP. The MURR1 antibody
efficiently immunodepleted endogenous MURR1 but not b-
actin from the cell lysates used (Figure 1A), confirming the
specificity of this antibody (Klomp et al, 2003).
In order to delineate the domains involved in the interac-
tion between MURR1 and XIAP, further coprecipitation ex-
periments were performed. Full-length XIAP or various
truncated forms that lack known domains (Figure 1B) were
expressed in 293 cells as GST fusion proteins and tested for
their ability to bind MURR1. The three BIR domains of XIAP
were found to be sufficient for interaction with MURR1, while
the spacer region between the BIRs and the RING domain, as
well as the RING itself, were not required (Figure 1C, left
panels). To more finely map the interacting domain in XIAP
responsible for MURR1 binding, precipitation experiments
were subsequently performed utilizing individual BIRs ex-
pressed in fusion with GST. These experiments demonstrated
that BIR 3 was sufficient for binding to MURR1; neither BIR 1
nor 2 bound to MURR1 (Figure 1C, middle panels). To
determine whether XIAP utilizes the same mechanism to
bind caspases and MURR1, a double point mutant of XIAP
that we have previously shown to be incapable of binding
caspases (Bratton et al, 2002; Silke et al, 2002) was tested for
its ability to bind MURR1. This mutant readily coprecipitated
MURR1 (Figure 1C, right panels), indicating that the mechan-
ism utilized by XIAP to bind MURR1 is distinct from that used
to bind caspases.
The ability of MURR1 to bind to other 3-BIR-containing
IAPs was also examined. MURR1 in fusion with GST
(MURR1–GST) or GST alone were transfected into 293 cells
and tested for their ability to coprecipitate c-IAP1, c-IAP2, or
NAIP. MURR1–GSTwas able to bind to c-IAP2 and NAIP, but
not to c-IAP1 (Figure 1D).
Cellular localization of MURR1
In order to determine the cellular localization of MURR1 and
XIAP, fusions of both proteins with either YFP or CFP were
generated and expressed in cells and subsequently examined
by fluorescence confocal microscopy. A MURR1–YFP fusion
protein exhibited a cytoplasmic localization with accumula-
tion of the protein in discrete perinuclear foci; coexpression
of MURR1–YFP with CFP–XIAP revealed the colocalization of
these two proteins within these foci, in addition to a more
diffuse, cytoplasmic pattern (Figure 2A, upper panels). CFP
was distributed diffusely throughout the cell and did not
colocalize in perinuclear foci with MURR1–YFP (Figure 2A,
middle panels). Similarly, CFP–XIAP when coexpressed with
YFP demonstrated a diffuse predominantly cytoplasmic pat-
tern and no perinuclear foci were noticeable (Figure 2A,
lower panels). These data are consistent with specific colo-
calization of MURR1–YFP and CFP–XIAP within these foci.
To further characterize the subcellular distribution of
MURR1, staining experiments were performed with cell-
permeable dyes specific for mitochondria or lysosomes in
cells transfected with MURR1–GFP. As shown in Figure 2B,
MURR1 was found to localize in a perinuclear compartment
that does not represent mitochondria or lysosomes.
MURR1 is not involved in the regulation
of caspase-mediated cell death
Since XIAP is a strong suppressor of apoptosis due to its
caspase-inhibiting properties, the possibility that MURR1
might function to modulate the protective properties of
XIAP was tested. Using experimental systems in which
XIAP has been previously shown to inhibit cell death effec-
tively (Richter et al, 2001), no modulatory activity of MURR1
was detected, as evaluated by morphological criteria for cell
viability or enzymatic evidence of caspase activation. This
was the case for the induction of apoptosis by ectopic
expression of Bax (Figures 3A and B) or Fas (Figures 3C
and D). These data suggest that MURR1 does not play a
significant role in regulating the ability of XIAP to inhibit
caspase-dependent cell death following these stimuli.
XIAP affects intracellular copper levels
The identification of the interaction between XIAP and
MURR1, a factor whose mutation results in copper toxicosis
in dogs (van De Sluis et al, 2002; Klomp et al, 2003), led us to
investigate whether XIAP itself could modulate copper home-
ostasis. First, the effect of decreased MURR1 protein expres-
sion in cultured cells was examined. Transfection of short
interfering RNA (siRNA) oligonucleotides targeting MURR1
resulted in increased intracellular copper levels in 293 cells
(Figure 4A), an effect consistent with the observed phenotype
in animals carrying mutations in this gene. The effects of
changes in XIAP protein levels on copper homeostasis were
subsequently examined. Ectopic expression of XIAP resulted
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in increased copper levels (Figure 4B). In addition, trans-
formed fibroblasts derived from Xiap-deficient mice con-
tained reduced copper levels when compared to
transformed fibroblasts derived from wild-type controls
(Figure 4C). Similarly, the copper content in liver tissue
from Xiap-deficient mice was lower when compared to sex-
and age-matched wild-type control animals (Figure 4D).
Therefore, decreased XIAP expression led to decreased cop-
per levels in cultured cells and animal tissues.
XIAP promotes the ubiquitination and degradation
of MURR1
The data shown in Figure 4 demonstrate that XIAP expression
levels were directly proportional to intracellular copper le-
vels. In contrast, MURR1 protein levels inversely correlated
with intracellular copper content. These findings suggested
the possibility that XIAP could be a negative regulator of
MURR1. In the course of our experiments, it was noticed
that alterations in XIAP protein levels in cells resulted in
Figure 1 XIAP and MURR1 interactions in mammalian cells. (A) Coprecipitation of endogenous MURR1 and XIAP: 293 cells were lysed in a
buffer containing 0.5% Triton X-100. Immunoprecipitation of endogenous proteins was performed using a rabbit polyclonal antibody against
MURR1 or normal rabbit Ig. The precipitated material was used for a Western blot for XIAP (top panel) and the supernatants after
immunoprecipitation were immunoblotted for MURR1 (middle panel) and b-actin (bottom panel). (B) Schematic of deletion constructs:
truncations in XIAP as shown in this schematic were expressed in mammalian cells in fusion with GSTand used as shown in (C). (C) Deletion
mapping: 293 cells were cotransfected with C-terminal Flag-tagged MURR1 together with vectors expressing GST fusion proteins with XIAP
full-length and various truncated forms as indicated. In addition, GST-3xBIR wild-type, or GST-3xBIR D148A/W310A were also used in these
experiments (right panels). Cell lysates prepared with a buffer containing 0.5% Triton X-100 were used for precipitations with glutathione
beads. The precipitated material was immunoblotted with Flag antibodies. (D) Coprecipitation of other 3-BIR containing IAPs: 293 cells were
transfected with either MURR1–GST or GST together with Myc6-c-IAP2 or Myc6-NAIP. Cell lysates prepared with a buffer containing 0.5%
Triton X-100 were used for precipitations using glutathione sepharose beads. The precipitated material was immunoblotted with Myc antibody
or c-IAP1 antibody.
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changes in MURR1 expression. Transfection of XIAP led
to decreased MURR1 protein levels and, conversely, a reduc-
tion in endogenous XIAP protein levels by RNAi led to
increased levels of MURR1 protein (Figure 5A). Similarly,
transfection of an XIAP mutant (H467A) that lacks E3 ubi-
quitin ligase activity (Yang et al, 2000) also resulted in
increased MURR1 protein levels, mimicking the effects
induced by RNAi of XIAP. These observations suggested
that, under basal conditions, MURR1 protein levels are
regulated by ubiquitination and proteasomal degradation in
a manner that is stimulated by the E3 ubiquitin ligase activity
of XIAP.
The effect of proteasomal blockade on MURR1 protein
levels was examined next. Treatment with lactacystin, a
highly specific proteasome inhibitor, led to progressive accu-
mulation of MURR1; in cells transfected with XIAP the
accumulation of MURR1 protein also occurred but to a lesser
extent (Figure 5B, left). These data indicate that basal levels
Figure 2 Localization of fluorescently tagged MURR1. (A) Colocalization of fluorescently tagged MURR1 and XIAP: 293 cells plated onto
coverglass chamber slides were transfected with MURR1 fused with YFP (MURR1–YFP) and XIAP fused with CFP (CFP–XIAP) (top panels), or
MURR1–YFP and CFP (middle panels), or YFP and CFP–XIAP (lower panels). Counterstaining of the nuclei was also performed using Hoechst
33342 (displayed in red for clarity). The scale bar shown corresponds to 18mm. (B) MURR1 does not colocalize with mitochodrial or lysosomal
markers: MURR1–GFP was transfected into 293 cells seeded on coverglass chambered slides. After 24 h the cells were stained with the vital
dyes Mitotracker (left panel) or Lysotracker (right panel) (Molecular Probes). Scale bars correspond to 18 mm.
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of MURR1 are regulated by proteasomal degradation and that
XIAP accelerates this process.
To determine whether MURR1 is indeed ubiquitinated,
in vitro translated and radiolabeled MURR1 was incubated
with a mammalian ubiquitin conjugating enzyme fraction
extracted from HeLa cell lysates, and subsequently resolved
by polyacrylamide gel electrophoresis and fluorography. A
ladder comprised of MURR1 species with progressively high-
er molecular weights was detected (Figure 5C, left), indicat-
ing that MURR1 can be readily ubiquitinated in vitro. The
ability of MURR1 to be ubiquitinated in intact cells was also
examined. A mammalian expression vector encoding
MURR1–GST was expressed in 293 cells and these cells
were treated with lactacystin for 8 h. Lysates were precipi-
tated with glutathione sepharose beads under stringent buffer
conditions (RIPA buffer), and the precipitated material was
immunoblotted for ubiquitin. High levels of ubiquitinated
MURR1–GST were detected, while no ubiquitination of the
control GST protein was observed (Figure 5C, right). These
data indicate that MURR1 is ubiquitinated.
The ability of XIAP to promote the ubiquitination of
MURR1 was examined next . A mammalian expression vector
encoding MURR1–GST was transfected into 293 cells along
with XIAP or a vector control. Under these conditions, which
did not include the addition of proteasome inhibitors, ubiqui-
tinated material of progressively higher molecular weight
was observed when MURR1 was cotransfected with XIAP
but not with the empty control vector (Figure 5D, top panel).
In addition, a significant reduction of MURR1–GST protein
levels after XIAP transfection was also observed (Figure 5D,
middle panel), consistent with the findings shown in
Figure 5A.
Interestingly, transfection of XIAP H467A led to greater
recovery of ubiquitinated MURR1 when compared to trans-
fection of vector or wild-type XIAP (Figure 5D, top panel).
However, MURR1–GST protein levels were observed to in-
crease following coexpression of XIAP H467A (Figure 5D,
middle panel), consistent with the observed effect shown in
Figure 5A. Similarly, in the absence of proteasomal inhibi-
tion, RNAi of XIAP also led to accumulation of ubiquitinated
MURR1 (see the third panel in Figure 5E), while as shown
before, MURR1 protein levels actually increased.
These findings raised the possibility that the ubiquitinated
species accumulating in cells transfected with XIAP H467A or
after RNAi of XIAP are not being targeted for proteasomal
degradation. To test this hypothesis, the accumulation of
ubiquitinated species after proteasomal inhibition was inves-
tigated. Cells transfected with wild-type XIAP and treated
with lactacystin for 3 h accumulated ubiquitinated MURR1 to
a greater extent than vector transfected cells (Figure 5E, first
Figure 3 MURR1 does not affect the antiapoptotic activities of XIAP. Expression vectors encoding Bax (A and B) or Fas (C and D) were
transfected into 293 cells either with empty vector controls or XIAP, MURR1 or both, together with a plasmid expressing EGFP as a marker of
transfection. Cell viability was assessed by morphology of EGFP-positive cells 16 h (A) or 30h (C) post-transfection, and caspase-3 activity was
determined in the same cells (B and D). Data presented represent the average and s.e.m. of three measurements per group.
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and second panels, top). In addition, MURR1–GST protein
levels, which were greatly reduced in untreated cells and only
noticeable upon long exposures, were stabilized after protea-
somal blockade (Figure 5E, first and second panels, middle).
While transfection of XIAP H467A led to accumulation of
ubiquitinated material in untreated cells, 3 h of lactacystin
treatment caused no further increase in ubiquitinated MURR1
or MURR1–GST input levels in cells transfected with XIAP
H467A (Figure 5E, first and second panels, top and middle).
Similarly, RNAi of XIAP also led to the accumulation of
ubiquitinated MURR1 in untreated cells, but ubiquitinated
material increased very little after proteasomal inhibition, in
contrast to control transfected cells (Figure 5E, third and
fourth panels). Taken together, these data indicate that
wild-type XIAP accelerates the formation of ubiquitinated
material that is targeted to the proteasome for degradation.
Blockade of XIAP-mediated ubiquitination by transfection of
XIAP H467A or RNAi of XIAP therefore revealed the existence
of an alternative pathway of MURR1 ubiquitination that is
insensitive to proteasomal blockade and that does not lead to
degradation of MURR1.
The effect of complete absence of Xiap on Murr1 protein
levels was investigated using fibroblasts derived from the
Xiap-deficient mice. When compared to wild-type fibroblasts,
Xiap / fibroblasts demonstrate a modest but reproducible
increase in Murr1 protein levels (Figure 5F). Other previously
described targets of XIAP-mediated ubiquitination (Suzuki
et al, 2001b; MacFarlane et al, 2002) also showed modest
increases (caspase-3) or no increase (DIABLO).
K48-independent polyubiquitination of MURR1
As noted above, blockade of XIAP-mediated ubiquitination of
MURR1 by transfection of the catalytically inactive mutant
XIAP H467A or after RNAi of XIAP leads to the accumulation
of ubiquitinated MURR1 that is not targeted for proteasomal-
mediated degradation. This situation has been observed
previously for unrelated proteins, and would occur if the
polyubiquitin chains on MURR1 are not linked at lysine 48
(K48) of ubiquitin (Aguilar and Wendland, 2003).
To test this hypothesis, MURR1 ubiquitination was evalu-
ated by a method that allowed us to compare the incorpora-
tion into polyubiquitinated MURR1 of wild-type ubiquitin
and a K48R point mutant of ubiquitin that cannot be con-
jugated into K48 polyubiquitin chains. In this approach,
MURR1–Flag was cotransfected with His6-tagged ubiquitin
expression vectors, and nickel-coated agarose beads were
used to precipitate ubiquitinated proteins. Immunoblott-
ing of the precipitated material with Flag antibody was
Figure 4 Copper levels are regulated by XIAP. 293 cells were transiently transfected with siRNA oligonucleotides or plasmids as indicated.
Copper levels were measured by atomic absorption and corrected for cell number in each sample. The effect of RNAi of MURR1 is shown in (A)
and the effect of transient transfection of XIAP is shown in (B). Similar experiments were performed with transformed fibroblasts derived from
wild-type and Xiap-deficient mice (C). Copper content in liver tissue obtained from Xiap-deficient mice and age- and sex-matched wild-type
controls is presented in (D). Each graph depicts all data points from multiple independent experiments. The mean and s.e.m. bars are also
shown. A Student’s t-test was performed, and the P-value is indicated in the graph panel. Western blots for MURR1 or XIAP are included below
each panel as indicated.
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performed to detect ubiquitin-conjugated MURR1. Using
wild-type ubiquitin in the experiment, transfection of wild-
type XIAP resulted in increased recovery of ubiquitinated
MURR1 (Figure 6A, left). Similar to the results shown in
Figure 5D, transfection of XIAP H467A along with wild-type
ubiquitin resulted in even greater levels of ubiquitinated
MURR1. Following transfection of ubiquitin K48R, ubiquiti-
nated MURR1 was recovered, demonstrating that non-K48
polyubiquitin chains could also be added to MURR1. In
contrast to the pattern of ubiquitination observed with
wild-type ubiquitin, the amount of polyubiquitinated
MURR1 containing the K48R ubiquitin mutant was not
Figure 5 XIAP targets MURR1 for ubiquitination and degradation. (A) MURR1 protein levels are regulated by XIAP: 293 cells were transfected
with pEBB–XIAP, pEBB–XIAP H467A or vector control or with siRNA oligonucleotides targeting GFP or XIAP. MURR1–Flag was cotransfected
and expression was determined by Western blot using Flag antibodies. The same membrane was probed for b-actin and for XIAP. (B) MURR1
protein levels are regulated by proteasomal degradation: 293 cells were transfected with MURR1–Flag and protein levels were determined by
Western blot using Flag antibodies. The cells were cotransfected with XIAP or a vector control and treated with lactacystin (10mM) for the time
indicated. (C) MURR1 is ubiquitinated in vitro and in intact cells: in vitro translated and 35S-labeled MURR1 was used as substrate for in vitro
ubiquitination (left). Ubiquitination was also studied in intact cells. 293 cells were transfected as indicated. One day after transfection, cells
were treated with lactacystin (10mM) for 8 h, and lysed in RIPA buffer. Lysates were precipitated with glutathione sepharose beads and
analyzed by Western blot using ubiquitin antibodies (right). (D) Effect of XIAP on MURR1 ubiquitination: 293 cells were transfected as
indicated. One day after transfection, cells were lysed in RIPA buffer and precipitation was performed using glutathione sepharose beads. The
precipitated material was used for Western blot with ubiquitin antibodies. (E) Effect of XIAP in the accumulation of ubiquitinated MURR1 after
lactacystin treatment: 293 cells were transfected as indicated; 1 day later, half of the cultures were treated with lactacystin (10mM) for an
additional 3 h. Cell lysates were prepared with RIPA buffer and precipitated with glutathione sepharose beads. The precipitated material was
used for Western blot with ubiquitin antibodies. (F) Murr1 protein levels in Xiap-deficient fibroblasts: cell lysates from wild-type and Xiap-
deficient fibroblasts were used for Western blot and immunoblotted as indicated.
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affected by XIAP (Figure 6A, right). These results demon-
strate that in addition to K48 polyubiquitin chains targeting
MURR1 to proteasomal degradation, non-K48 polyubiquitina-
tion of MURR1 can also be detected and this pathway is
independent of XIAP.
This alternative pathway of ubiquitination was uncovered
by RNAi of XIAP and similarly by transfection of XIAP
H467A. The ability of this catalytically inactive mutant to
act as a dominant-negative molecule could result from bind-
ing to MURR1 in a manner that prevents its ubiquitination by
endogenous wild-type XIAP. Indeed, under stringent immu-
noprecipitation conditions (RIPA buffer), MURR1 was found
to bind much more strongly to XIAP H467A than to wild-type
XIAP (Figure 6B, left). Interestingly, proteasomal blockade
also led to increased binding to MURR1of both wild-type
XIAP and XIAP H467A, although the binding to XIAP H467A
remained stronger (Figure 6B, right).
Discussion
In this study, we have characterized a novel property of XIAP
in copper homeostasis through its ability to ubiquitinate the
copper regulating factor, MURR1. An association between
these two proteins was first identified in a yeast two-hybrid
screen, and was subsequently confirmed by coprecipitation
experiments with both endogenous and ectopically expressed
proteins. Deletion mapping of XIAP revealed that BIR 3 is
necessary and sufficient for binding to MURR1. MURR1 was
found to bind to XIAP even after critical residues required for
interaction with caspase-3 (D148) and caspase-9 (W310) had
been mutated, thus abrogating caspase binding (Bratton et al,
2002; Silke et al, 2002) (Figure 1D). This suggests that the
mechanism involved in MURR1 binding to XIAP is distinct
from that utilized by caspases, Smac/DIABLO and Omi/
HtrA2 (Shi, 2002). Processed caspase-9, Smac/DIABLO and
Omi/HtrA2 bind to a defined region in BIR 3 through an
amino-terminal tetrapeptide element present in the mature
forms of these proteins. Consistent with our observation that
a critical mutation in the caspase-9 binding pocket (W310A)
does not affect MURR1 binding, we have not identified a
canonical tetrapeptide IAP binding motif in MURR1. In addi-
tion, MURR1 can bind to other IAPs, such as c-IAP2 and
NAIP, although the functional significance of such associa-
tions remains to be elucidated.
MURR1 has been implicated in the regulation of copper
homeostasis in mammals. This gene was found by positional
cloning to be responsible for an autosomal recessive form of
copper toxicosis that affects a specific canine strain (van De
Sluis et al, 2002). The MURR1 mutation results in loss of
protein expression in affected animals (Klomp et al, 2003).
Copper is essential for the enzymatic activity of a number of
housekeeping genes, including Cu,Zn superoxide dismutase,
and it can play a pathophysiologic role in oxidative stress
damage through its ability to induce free radical formation
(Mercer, 2001). The regulation of copper homeostasis in
mammalian cells is a complex process involving high-affinity
copper transporters that can mediate copper uptake or efflux
from the cell, as well as copper chaperones involved in the
transfer of copper ions to certain copper-binding proteins
(Puig and Thiele, 2002). The precise mechanism by which
MURR1 is involved in copper regulation remains unknown,
although an association between MURR1 and the copper
transporter ATP7B has been recently described (Tao et al,
2003). Utilizing RNAi to decrease the endogenous levels of
MURR1, we show here the first biochemical evidence that
deficiency of this protein can indeed lead to copper accumu-
lation in cultured cells. Given that ATP7B expression is
largely restricted to the liver and brain (Puig and Thiele,
2002), the effects on cellular copper levels observed in our
studies using 293 cells and fibroblasts suggest that mechan-
isms involving other molecular targets are possibly impli-
cated as well.
Although we did not find a role for MURR1 in the control
of apoptosis by XIAP, we did find an effect of XIAP expression
on copper levels. Increased levels of XIAP expression led to
copper accumulation in several cell models, and Xiap defi-
ciency in mice led to decreases in copper content in hepatic
tissue. These findings support a physiological role for the
interaction between MURR1 and XIAP. In addition, this
represents the first phenotypic alteration reported in Xiap-
Figure 6 Non-K48 ubiquitination of MURR1. (A) Non-K48-linked
ubiquitination of MURR1: 293 cells were transfected with either
wild-type His6-tagged ubiquitin or a K48R mutant of ubiquitin along
with MURR1–Flag. In addition, XIAP wild-type, XIAP H467 or a
vector control were also transfected, as indicated. Two days after
transfection, cell lysates were prepared and used for precipitation
with Ni–NTA agarose beads. The precipitated material was immu-
noblotted with Flag antibodies. Molecular weight markers are in
kilodaltons. (B) Binding of XIAP H467A to MURR1 and the effects of
proteasome inhibition: 293 cells were transfected as indicated and 1
day later half of the cultures were treated with lactacystin (10mM)
for an additional 6 h. Cell lysates were then prepared with RIPA
buffer and precipitated with glutathione sepharose beads. The
precipitated material was immunoblotted for XIAP. (C) Schematic
representation of MURR1 ubiquitination pathways and the role of
XIAP.
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deficient mice, which do not have detectable defects in the
regulation of apoptotic cell death (Harlin et al, 2001).
The effect of XIAP expression on copper regulation was the
opposite of that observed for MURR1. Consistent with this,
our studies demonstrate that XIAP negatively regulates
MURR1 protein levels. Expression of wild-type XIAP led to
reductions in MURR1 levels. Conversely, reduction of endo-
genous levels of XIAP by RNAi or expression of XIAP H467A,
harboring a point mutation that abolishes its E3 ubiquitin
ligase activity, led to increased MURR1 protein levels. The
studies presented here demonstrate that the ability of XIAP
to reduce MURR1 protein levels is mediated by ubiquitination
and proteasomal degradation of MURR1. Proteasomal block-
ade with lactacystin led to increased MURR1 levels demon-
strating that under basal conditions, MURR1 protein levels
are subject to a constant rate of degradation. In addition, this
effect also occurred in XIAP-transfected cells, although to a
lesser extent, suggesting that XIAP accelerates the process of
proteasomal degradation of MURR1. Indeed, increased
amounts of ubiquitinated MURR1 could be recovered after
transfection of wild-type XIAP, and after proteasomal block-
ade this material accumulated to a greater extent in XIAP-
transfected cells, indicating that the ultimate fate of this
ubiquitinated material is its degradation by the proteasome.
Finally, consistent with a role for XIAP in the regulation of
basal levels of MURR1, Xiap-deficient fibroblasts had modest
increases in Murr1 protein levels. The modest changes ob-
served in protein levels may represent the upregulation of yet
undetermined compensatory changes in these cells, and other
presumed targets of XIAP-mediated ubiquitination (Suzuki
et al, 2001b; MacFarlane et al, 2002) such as Smac/DIABLO
or caspase-3 are either unchanged or only minimally elevated
in these cells.
Interestingly, an increase in ubiquitinated MURR1 was also
observed following transfection of XIAP H467A or RNAi of
endogenous XIAP, although total MURR1 protein levels also
increased, strongly suggesting that this polyubiquitinated
material was not being targeted for proteasomal degradation.
Consistent with this interpretation, proteasomal blockade did
not lead to further accumulation of ubiquitinated MURR1 in
cells transfected with XIAP H467A or after RNAi of XIAP.
Proteasome-mediated degradation of proteins occurs when
polyubiquitin chains of four or more ubiquitin molecules
linked at lysine 48 of ubiquitin are added to the target protein
(Thrower et al, 2000). However, other forms of polyubiquitin
branches that are generally not degraded by the proteasome
have been described; these may instead play distinct roles in
signal transduction (Deng et al, 2000). As shown here,
polyubiquitination of MURR1 in a manner that does not
require K48 of ubiquitin was found, and our data indicate
that this process is XIAP-independent, likely resulting from
(an) as yet unidentified E3(s) that target(s) MURR1
(Figure 6C). The nature of the lysine involved in the branch-
ing of these polyubiquitin chains and their functional sig-
nificance remain to be determined. In addition, the data
suggest that, under basal conditions, XIAP regulates the
rate of MURR1 ubiquitination through this alternative path-
way, perhaps through substrate competition. When basal
XIAP activity is suppressed, as a result of RNAi of endogen-
ous XIAP or transfection of the catalytically inactive H467A
mutant, nondegradable ubiquitinated MURR1 readily accu-
mulates, likely as a result of the unimpeded activity of this
alternative ubiquitination pathway. Depending on the func-
tional significance of non-K48 polyubiquitinated MURR1, the
regulation of the cellular pool of this material might be
another level at which XIAP can regulate MURR1 activity.
The ability of XIAP H467A to have a dominant-negative
effect on XIAP-mediated regulation of MURR1 could result
from the ability of this molecule to bind to MURR1 with even
greater affinity than wild-type XIAP. The reason for this
increased affinity is unclear, but could implicate a contribu-
tion of the RING finger domain in the stability of the inter-
action. Alternatively, a factor(s) that stabilize(s) MURR1–
XIAP interactions might also accumulate after transfection
of XIAP H467A. This possibility is partially supported by the
fact that proteasomal inhibition also increases the affinity of
the interaction to a degree that cannot be simply explained by
accumulation of the proteins.
Overall, these results are consistent with a model in which
XIAP regulates copper levels through its ability to negatively
regulate MURR1 by directing the ubiquitination and protea-
somal degradation of this molecule. The data also demon-
strate the presence of an alternative ubiquitination pathway
for MURR1 that is K48-independent and that, under basal
conditions, is likely suppressed by XIAP. While a role for
XIAP can be envisaged as a general sensor of cellular stress,
possible relationships between its seemingly unrelated func-
tions, including caspase inhibition, TGF-b signaling and
copper regulation, remain to be elucidated.
Materials and methods
Yeast two-hybrid screening
A GAL4-based system was used (Fields and Song, 1989) (Match-
maker GAL4 two-hybrid system 3, Clontech). Full-length XIAP was
cloned into pGBKT7; this plasmid was transformed into yeast and
no spontaneous transactivation was noted. The transformed yeast
were expanded and mated with yeast pretransformed with a liver
cDNA library (Clontech). A total of 4106 transformants were
screened.
Plasmids and siRNA oligonucleotides
The MURR1 clone obtained from the cDNA library containing
amino acids 4–190 of the protein (pAct2-MURR1) was subcloned
into pCMV-HA (Clontech). The coding sequence for the first three
amino acids was cloned in frame using synthetic oligonucleotides.
pEBB–MURR1–Flag and pEBB–MURR1–GST were constructed by
PCR of MURR1 using pCMV–HA full-length MURR1 as template.
pcDNA3.1(þ ) MURR1 and pMURR1–DsRed2 were constructed by
inserting full-length MURR1 into pcDNA3.1(þ ) and pDsRed2-N1,
respectively. pEBB–CFP and pEBB–YFP were constructed by
inserting PCR fragments for CFP and YFP into pEBB. pEBB–CFP–
XIAP and pEBB–MURR1–YFP were similarly constructed by
inserting CFP and YFP into the 50 end of pEBB–XIAP and the 30
end of pEBB–MURR1–Flag, respectively. pEBG–BIR 1, pEBG–BIR 2,
pEBG–BIR 3 and pEBG–BIR 1–2 were generated by PCR using
pEBB–XIAP as template, with the boundaries for each construct as
indicated in Figure 1B. Other pEBB-derived plasmids used here have
been described previously (Duckett et al, 1998; Richter et al, 2001).
Plasmid pCW7-His6-Ub has also been described (Yu and Kopito,
1999); the K48R mutation in ubiquitin was introduced by site-
directed mutagenesis. For RNA interference (RNAi), double-
stranded RNA oligonucleotides (Xeragon/Qiagen) targeting the
following gene-specific sequences were used: AAGTGGTAG
TCCTGTTTCAGC (XIAP coding sequence nucleotides 111–131),
AAGTCTATTGCGTCTGCAGAC (MURR1 coding sequence nucleo-
tides 178–198) and AAGACCCGCGCCGAGGTGAAG (GFP coding
sequence nucleotides 322–342).
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Cell culture and transfection
Human embryonic kidney 293 cells and transformed fibroblasts
were cultured in DMEM supplemented with 10% FBS and 2mM L-
glutamine. A standard calcium phosphate transfection protocol
(Duckett et al, 1997) was used to transfect 293 cells; this was the
case for both plasmids and siRNA oligonucleotides.
Caspase assays
Floating and attached cells were harvested and caspase-3 assays
were performed using the ApoTarget protease assay kit (BioSource)
according to the manufacturer’s instructions. Caspase activity was
measured for 2 h at 90-s intervals on a Cytofluor 4000 fluorescence
plate reader (Perseptive Biosystems) as described previously
(Richter et al, 2001).
In vitro ubiquitination assay
MURR1 was translated in vitro using pcDNA3.1 (þ ) MURR1 as
template in the presence of 35S-labeled methionine and cysteine
(Amersham) following the manufacturer’s instructions (Promega).
The in vitro ubiquitination reaction utilized 35S-labeled MURR1 as
substrate for a mammalian ubiquitin conjugating enzyme fraction
extracted from HeLa cell lysates containing a mixture of E1, E2 and
E3 enzymes with the addition of ubiquitin aldehyde (Boston
Biochem) according to the manufacturer’s instructions.
Western blot, antibodies and immunoprecipitation
Cell lysates were prepared as previously described (Richter et al,
2001). The lysis buffers used were RIPA (PBS, 1% NP-40, 0.5%
sodium deoxycholate, 0.1% SDS) and a buffer containing 0.5%
Triton X-100 (25mM HEPES, 100mM NaCl, 1mM EDTA, 10%
glycerol), as indicated in each experiment. In both cases, the lysis
buffer was supplemented with 1mM Na3VO4, 1mM PMSF, one
protease inhibitor tablet (Roche) per 10ml of buffer, 10mM DTT
and 1mM NaF.
Protein samples were resolved using 4–12% gradient Novex Bis-
Tris gels (Invitrogen), transferred to nitrocellulose membranes
(Invitrogen) and blocked with 5% milk solution in TBS containing
0.05–0.2% Tween-20 (depending on the antibody). The membranes
were incubated with primary antibodies as indicated, followed by
incubation with HRP-conjugated sheep anti-mouse or donkey anti-
rabbit secondary antibodies (Amersham). Antibody detection was
performed by an enhanced chemiluminescence (ECL) Western blot
detection system (Amersham) according to the manufacturer’s
instructions.
A polyclonal MURR1 antiserum was used; further characteriza-
tion of this antibody has been described elsewhere (Klomp et al,
2003). A previously described mouse monoclonal antibody raised
against a fragment of c-IAP1 lacking the first BIR was used (Harlin
et al, 2001). Mouse monoclonal antibodies against XIAP (Transduc-
tion Labs, 59520), Flag (Sigma, A8592), b-actin (Sigma, A5441),
Myc (Covance, 9E10) and ubiquitin (Affinity, FK2) were also used.
For MURR1 immunoprecipitation, polyclonal antibody was
added to the cell lysate and incubated at 41C. After 1 h, protein G
agarose beads (Invitrogen) were added and the samples were
incubated for an additional 2 h. For precipitations of GST-tagged
proteins and for precipitation of His6-ubiquitin conjugated proteins,
glutathione sepharose beads (Amersham) or nickel agarose beads
(Invitrogen) were added and the samples were incubated at 41C for
3–6 h, respectively. In all precipitation experiments, the beads were
washed four times with lysis buffer and pelleted material was
resuspended in LDS loading buffer (Invitrogen) and used for
immunoblotting as described above.
Confocal and fluorescence microscopy
Morphological assays for cell viability were performed by observing
EGFP fluorescent cells with a Leica DM IRB inverted fluorescence
microscope. Images for MURR1 localization experiments were
obtained from live cells plated onto coverglass chambers utilizing a
Zeiss Axiovert 100M confocal microscope equipped with a Zeiss
LSM 510 Meta spectrometer. Nuclear counterstaining was per-
formed by adding Hoechst 33342 to phenol-red-free culture media
to a final concentration of 5mg/ml.
Copper measurements
Cells were harvested and washed three times in PBS. After the last
wash, the cells were counted twice and pelleted. The cell pellet was
digested by refluxing in Ultrex nitric acid for 2 h. The excess nitric
acid was removed by evaporation and the residue was dissolved in
0.5% nitric acid. Copper levels were determined by atomic
absorption in duplicate or triplicate for each sample using an
IL451 single-beam flame spectrophotometer. The copper content
obtained was expressed as micrograms of copper per million cells,
and these values were used to calculate fold relationships between
samples. For measurements of copper content in liver tissue,
samples were first dried in a 651C vacuum oven and then processed
in a similar way as cell pellets. The copper content obtained from
these samples was expressed as micrograms of copper per gram of
dry tissue.
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